Genomictree Inc. (KOSDAQ:228760)
16,960
+200 (1.19%)
Apr 10, 2026, 3:30 PM KST
Genomictree Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 16,315 | 26,350 | 45,269 | 67,572 | 66,461 |
Short-Term Investments | 61,051 | 69,730 | 47,877 | 47,033 | 64,081 |
Cash & Short-Term Investments | 77,366 | 96,080 | 93,146 | 114,605 | 130,542 |
Cash Growth | -19.48% | 3.15% | -18.72% | -12.21% | 26.59% |
Accounts Receivable | 384.04 | 332.5 | 388.29 | 1,031 | 2,267 |
Other Receivables | 273.45 | 274.54 | 286.19 | 144.11 | 28.22 |
Receivables | 657.49 | 607.04 | 674.47 | 1,175 | 2,295 |
Inventory | 265.3 | 334.58 | 496.53 | 635.45 | 284.87 |
Prepaid Expenses | 42.24 | 105.9 | 395.89 | 424.22 | 502.98 |
Other Current Assets | 574.12 | 534.92 | 657.95 | 1,160 | 702.45 |
Total Current Assets | 78,905 | 97,662 | 95,371 | 118,000 | 134,327 |
Property, Plant & Equipment | 19,858 | 18,386 | 17,460 | 17,866 | 21,459 |
Long-Term Investments | 14,231 | 6,430 | 14,048 | 21,136 | 19,656 |
Other Intangible Assets | 1,241 | 1,250 | 1,336 | 1,470 | 1,523 |
Long-Term Deferred Charges | 0 | 0 | 20.92 | 83.67 | 146.43 |
Other Long-Term Assets | 6,526 | 6,947 | 4,608 | 4,354 | 40.12 |
Total Assets | 120,762 | 130,675 | 132,844 | 162,910 | 177,151 |
Accounts Payable | 76.89 | 66.89 | 66.79 | 132.6 | 87.57 |
Accrued Expenses | 1,498 | 1,445 | 1,433 | 1,821 | 441.27 |
Short-Term Debt | 2,301 | 1,972 | 1,690 | 29,043 | - |
Current Portion of Long-Term Debt | -0 | 0 | 0 | 0 | - |
Current Portion of Leases | 41.32 | 47.42 | 47.42 | 52.8 | 265.79 |
Current Income Taxes Payable | - | - | - | 1.7 | - |
Current Unearned Revenue | 2.01 | 1.03 | 0.64 | 9.8 | 28.6 |
Other Current Liabilities | 524.59 | 1,218 | 2,044 | 22,381 | 1,319 |
Total Current Liabilities | 4,445 | 4,751 | 5,281 | 53,442 | 2,142 |
Long-Term Debt | - | - | - | - | 37,271 |
Long-Term Leases | 24.81 | 59.98 | 97.52 | 84.63 | 907.61 |
Pension & Post-Retirement Benefits | 854.7 | 1,418 | 2,290 | 1,202 | 2,754 |
Long-Term Deferred Tax Liabilities | 103.3 | 92.97 | 92.97 | 579.61 | 206.6 |
Other Long-Term Liabilities | 24.55 | 33.78 | 49.94 | 44.39 | 18,770 |
Total Liabilities | 5,452 | 6,356 | 7,812 | 55,353 | 62,050 |
Common Stock | 12,191 | 12,181 | 12,006 | 10,513 | 10,164 |
Additional Paid-In Capital | 86,316 | 85,935 | 79,972 | 57,050 | 55,819 |
Retained Earnings | 12,037 | 20,602 | 31,274 | 39,976 | 46,434 |
Treasury Stock | -4,714 | -4,878 | -4,984 | -4,984 | - |
Comprehensive Income & Other | 9,239 | 10,045 | 6,468 | 4,345 | 2,296 |
Total Common Equity | 115,070 | 123,885 | 124,736 | 106,900 | 114,713 |
Minority Interest | 239.96 | 434.79 | 295.48 | 502.28 | - |
Shareholders' Equity | 115,310 | 124,320 | 125,032 | 107,557 | 115,101 |
Total Liabilities & Equity | 120,762 | 130,675 | 132,844 | 162,910 | 177,151 |
Total Debt | 2,368 | 2,079 | 1,835 | 29,180 | 38,444 |
Net Cash (Debt) | 74,998 | 94,001 | 91,312 | 85,425 | 92,098 |
Net Cash Growth | -20.21% | 2.94% | 6.89% | -7.25% | 0.57% |
Net Cash Per Share | 3121.55 | 3937.19 | 3444.88 | 4069.68 | 4461.03 |
Filing Date Shares Outstanding | 24.09 | 23.99 | 23.63 | 20.65 | 20.33 |
Total Common Shares Outstanding | 24.09 | 23.99 | 23.63 | 20.65 | 20.33 |
Working Capital | 74,460 | 92,912 | 90,090 | 64,557 | 132,185 |
Book Value Per Share | 4776.24 | 5163.99 | 5278.29 | 5177.78 | 5643.25 |
Tangible Book Value | 113,829 | 122,635 | 123,400 | 105,429 | 113,190 |
Tangible Book Value Per Share | 4724.73 | 5111.89 | 5221.76 | 5106.57 | 5568.33 |
Land | 7,855 | 7,699 | 7,981 | 7,924 | 9,612 |
Buildings | 5,622 | 5,703 | 6,167 | 6,100 | 8,064 |
Machinery | 10,946 | 8,775 | 6,102 | 6,016 | 4,524 |
Construction In Progress | 326.11 | 363.59 | 326.11 | 133.2 | 138.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.